TNF and arthritic joint disease: We have recently reported that a subset of recently activated, proinflammatory Teff (CPLs) is expanded in this very same cohort of patients resistant to anti-TNF therapy.11 As effector and regulatory mechanisms are unbalanced during active arthritis, we initially expected that the observed increase in activated Teff would be matched by a corresponding decrease in Treg cells.